[Conclusion: what is the choice of antibiotics in adult respiratory tract infections?].
TREATMENT OF SINUSITIS: For both acute rhinosinusitis in patients with no past history where S. pneumoniae and H. influenzae are the main causal agents, or recurrent sinusitis in a chronic background where anaerobic bacteria are increasingly implicated, pristinamycin is one of the rare compounds which can be expected to be effective and is a treatment of choice for an empirical strategy. LOWER RESPIRATORY TRACT INFECTIONS: Besides high-risk subjects with non-microbiologically proven bronchial infection, where enterobacteriaceae could involve a pristinamycin is a useful alternative to the conventional strategy (i.e.: amoxicillin, macrolides and cotrimoxazole) in the treatment of LRT infection.
Klossek
J M
JM
Mayaud
C
C
D000208:Acute Disease; D000328:Adult; D000658:Amoxicillin / Q000627:therapeutic use; D001982:Bronchial Diseases / Q000188:drug therapy; D001991:Bronchitis / Q000188:drug therapy; D005260:Female; D006801:Humans; D018942:Macrolides / Q000627:therapeutic use; D008297:Male; D012141:Respiratory Tract Infections / Q000188:drug therapy*; D012220:Rhinitis / Q000188:drug therapy; D012852:Sinusitis / Q000188:drug therapy; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000627:therapeutic use; D014769:Virginiamycin / Q000627:therapeutic use*
D018942:Macrolides; D014769:Virginiamycin; D000658:Amoxicillin; D015662:Trimethoprim, Sulfamethoxazole Drug Combination